Rekvina Laboratories Share Price
13 Oct, 2026 4:01 PM (IST)
Rekvina Laboratories Performance
- Today's Low
- ₹59
- Today's High
- ₹59
- 52 Week Low
- ₹7
- 52 Week High
- ₹59
- Open Price₹59
- Previous Close₹56
- Volume1,954
- 50 DMA₹48.00
- 100 DMA₹42.40
- 200 DMA₹34.20
Rekvina Laboratories Chart
Investment Returns
- Over 1 Month -0.62%
- Over 3 Month + 68.66%
- Over 6 Month + 48.06%
- Over 1 Year + 1211.78%
Smart Investing Starts Here Start SIP with Rekvina Laboratories for Steady Growth!
Rekvina Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -104.7
- PEG Ratio
- 1
- Market Cap Cr
- 36
- P/B Ratio
- -26.4
- Average True Range
- 1.3
- EPS
- -0.6
- Dividend Yield
- 0
- MACD Signal
- 1.8
- RSI
- 73.26
- MFI
- 32.9
Latest Stock News Updates
Appointment of Mr. Subrata Samanta as a Chief Financial officer of the company with effect from 07.10.2026.
- BSE India
- 6 days 8 hours ago
AGM Voting Results along-with Scrutinizer Report on E-Voting
- BSE India
- 2 weeks ago
Summary of Proceeding of Annual General Meeting
- BSE India
- 2 weeks ago
Rekvina Laboratories Financials
Rekvina Laboratories Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹52.40
- 50 Day
- ₹48.00
- 100 Day
- ₹42.40
- 200 Day
- ₹34.20
Resistance and Support
- R3 59.00
- R2 59.00
- R1 59.00
- S1 59.00
- S2 59.00
- S3 59.00
Rekvina Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-13 | Quarterly Results | |
| 2026-05-21 | Audited Results | |
| 2026-03-16 | Preferential Issue of shares | Inter-alia, to consider 1.Proposal for issuance equity shares/any other securities of the Company, by way of Preferential issue, in accordance with provisions of Securities & Exchange Board of India. |
| 2026-02-06 | Quarterly Results | |
| 2025-11-14 | Quarterly Results |
About Rekvina Laboratories
Rekvina Labs engaged in providing comprehensive diagnostic and testing services, including clinical pathology, biochemistry, microbiology, molecular diagnostics, and advanced imaging. The company operates with a commitment to accuracy, reliability, and innovation in medical testing, supported by state-of-the-art laboratory technology and a team of highly skilled professionals. By upholding the highest standards of quality and precision and plays a vital role in disease detection, prevention, and treatment support, serving hospitals, clinics, and individual patients with trusted diagnostic solutions. View More- NSE Symbol
- VINRKLB
- BSE Symbol
- 526075
- ISIN
- INE092O01028
Similar Stocks to Rekvina Laboratories
Popular Stocks
Rekvina Laboratories FAQs
Rekvina Laboratories share price is ₹59 As on 14 October, 2026 | 03:29
The Market Cap of Rekvina Laboratories is ₹35.6 Cr As on 14 October, 2026 | 03:29
The P/E ratio of Rekvina Laboratories is -104.7 As on 14 October, 2026 | 03:29
The PB ratio of Rekvina Laboratories is -26.4 As on 14 October, 2026 | 03:29
The 52 week High & Low of Rekvina Laboratories is ₹59.4/₹6.8 respectively As on 14 October, 2026 | 03:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.